Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD
4.52
-1.48 (-24.67%)
Dec 29, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2007
Selling, General & Admin
2.091.020.481.352.693.9608.331.510.48
Upgrade
Research & Development
1.580.080.341.10.1-1.3320.413.670.620.19
Upgrade
Other Operating Expenses
000000000.880
Upgrade
Operating Expenses
3.671.10.832.452.792.6320.41123.010.67
Upgrade
Operating Income
-3.67-1.1-0.83-2.45-2.79-2.63-20.41-12-3.01-0.67
Upgrade
Interest Expense / Income
00.8110.981.234.422.621.871.40.41
Upgrade
Other Expense / Income
-2.18-0.3--0.41-2.85-0.01-
Upgrade
Pretax Income
-1.48-1.61-1.82-3.42-4.43-7.05-25.88-13.87-4.42-1.08
Upgrade
Income Tax
00000000.0100
Upgrade
Net Income
-1.48-1.61-1.82-3.42-4.43-7.05-25.88-13.88-4.42-1.08
Upgrade
Shares Outstanding (Basic)
0000000000
Upgrade
Shares Outstanding (Diluted)
0000000000
Upgrade
Shares Change
151.51%56.01%-0.17%45.07%29.08%3.46%32.21%90.37%36.85%118.61%
Upgrade
EPS (Basic)
-31.20-84.00-151.20-282.00-528.00-1086.01-4140.04-2940.03-1800.02-600.01
Upgrade
EPS (Diluted)
-31.20-84.00-151.20-282.00-528.00-1086.01-4140.04-2940.03-1800.02-600.01
Upgrade
Free Cash Flow
-3.57-1.23-0.43-3.25-4.1-3.33-7.33-3.55-2.77-0.53
Upgrade
Free Cash Flow Per Share
-74.94-64.92-35.20-267.57-490.07-513.21-1168.40-747.58-1110.56-288.45
Upgrade
EBITDA
-1.48-0.81-0.83-2.45-3.2-2.63-23.26-11.99-3.02-0.67
Upgrade
Depreciation & Amortization
0000000000
Upgrade
EBIT
-1.48-0.81-0.83-2.45-3.2-2.63-23.26-12-3.02-0.67
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).